[Alzheimer's disease and genetics].
Arvid Rongve1, Dag Årsland, Caroline Graff
1Seksjon for alderspsykiatri, Klinikk for psykisk helsevern, Helse-Fonna, Haugesund, Norway. arvid.rongve@helse-fonna.no
Summary
Genetic factors significantly influence Alzheimer's disease risk. New gene discoveries are reshaping our understanding of disease mechanisms and paving the way for novel therapies.
Area of Science:
- Neurogenetics
- Dementia Research
- Molecular Biology
Context:
- Alzheimer's disease (AD) is the leading cause of dementia globally.
- Genetic factors play a crucial role in AD pathogenesis.
- Recent advancements have identified novel risk genes for AD.
Purpose:
- To summarize current knowledge on genetic factors associated with Alzheimer's disease.
- To review findings from genetic association studies and databases like Alzgene.
- To integrate literature searches and expert experience in dementia research.
Summary:
- Mutations in APP, PSEN1, and PSEN2 genes account for early-onset familial AD.
- Heritability for late-onset AD ranges from 60-80%, with APOE ε4 as a key risk factor.
- Genome-wide association studies identified ten new risk genes involved in cholesterol metabolism, immune response, and synaptic function.
Impact:
- New genetic insights are prompting revised hypotheses on AD mechanisms, moving beyond the amyloid pathway.
- Identification of novel risk genes offers potential for developing specific biomarkers for AD.
- These discoveries may lead to new therapeutic targets for disease-modifying treatments for Alzheimer's disease.
More Related Videos
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
09:33Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:11Genetic Lingo
Overview
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...